These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two support the notion of targeting ACKR3 as a singular strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-related Diseases. Disclaimer: The above is actually https://carolw692axt1.dreamyblogs.com/profile